insights_auto
Per què CONCORDBIO ha pujat 2,19%?
Aprofundeix méschevron_right
CONCORDBIO:NSE
Concord Biotech Ltd
1.360,00 ₹
arrow_upward
+2,19%(+29,20) 1d
9 d’oct., 15:30:01 GMT+5:30 · INR
search
Tots els sÃmbols
| SÃmbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadÃstiques principals per a CONCORDBIO...
Obre
1.336,00 ₹
Alt
1.370,00 ₹
Baix
1.326,00 ₹
Capitalització borsà ria
142,28Â kM
Volum mitjÃ
146,28Â k
Volum
128,35Â k
Dividend
0,56Â %
Dividend trimestral
1,89 ₹
Data de l'exdividend
24 de jul. 2026
RÃ tio preu-benefici
51,69
Alt 52 setmanes
1.627,00 ₹
Baix 52 setmanes
987,00 ₹
BPA
26,31 ₹
Nombre d'empleats
2Â k
Obre
1.336,00 ₹
Alt
1.370,00 ₹
Baix
1.326,00 ₹
Capitalització borsà ria
142,28Â kM
Volum mitjÃ
146,28Â k
Volum
128,35Â k
Dividend
0,56Â %
Dividend trimestral
1,89 ₹
Data de l'exdividend
24 de jul. 2026
RÃ tio preu-benefici
51,69
Alt 52 setmanes
1.627,00 ₹
Baix 52 setmanes
987,00 ₹
BPA
26,31 ₹
Nombre d'empleats
2Â k
NotÃcies
De fonts web i partners de notÃcies
Forbes
·
fa 7 minuts
Stock Market Crash Hits 54% Of Stocks—Is The S&P 500 Next?
Simply Wall Street
·
fa 31 minuts
Automatic Data Processing (ADP) After The Run Up Is Its Valuation Still Attractive
MarketBeat
·
fa 23 minuts
Eagle Financial Services Inc. (NASDAQ:EFSI) Stock Has Consensus Price Target of $43.75
Perfil
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Sobre Concord Biotech Ltd